Complete Genotype and Clinical Phenotype of Hemophilia B:  A Study on Iranian Patients

marzieh shakouri; Maryam Sadat Hosseini; Akbar Dorgalaleh; Minoo Shahidi; Farhad Zaker

doi:10.22037/jcma.v6i1.33722

Journal of Cellular & Molecular Anesthesia

Current Issue All Issues Accepted Manuscripts Search

Journal Information Editors & Boards Indexing and Listing Sources Journal Metrics Open Peer Review (OPR)Publication Ethics and Malpractice Statement Reviewer and AE Registration Form New Publisher Announcement Support Contact Us

APC

Authors Guide Submit Manuscript

https://doi.org/10.22037/jcma.v6i1.33722

Complete Genotype and Clinical Phenotype of Hemophilia B: A Study on Iranian Patients

Author(s):

marzieh shakouri^1,*,

Maryam Sadat Hosseini²,

Akbar Dorgalaleh¹,

Minoo Shahidi

¹,

Farhad Zaker³

1Department of Hematology and Blood Banking, School of Allied Medicine, Iran University of Medical Sciences, Tehran, Iran

2Department of Hematology and Blood Banking, School of Allied Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran

3Department of Hematology and Blood Banking, School of Allied Medicine, Iran University of Medical Sciences, Tehran, Iran; Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran

Journal of Cellular & Molecular Anesthesia:Vol. 6, issue 1; e150285

Published online:Jan 14, 2021

Article type:Original Articles

How to Cite:shakouri M, Hosseini MS, Dorgalaleh A, Shahidi M, Zaker F. Complete Genotype and Clinical Phenotype of Hemophilia B: A Study on Iranian Patients. J Cell Mol Anesth. 2021;6(1):e150285. doi: https://doi.org/10.22037/jcma.v6i1.33722

Abstract

Background: Hemophilia B which refers to the deficiency or functional defect of factor IX (FIX) is typically an X-linked bleeding condition that arises from heterogeneous mutations of the FIX gene (F9). The number of hemophilia cases in Iran is considerable and currently, about 1118 Iranian patients are suffering from hemophilia B, although a small number of them underwent genetic investigations. Here we assessed molecular defects and also laboratory and clinical findings of 10 Iranian cases with hemophilia B. Materials and Methods: A total of 10 cases with hemophilia B were enrolled in the study. Patients were clinically examined by a hematologist and their previous medical documents were surveyed carefully. Routine coagulation tests and FIX activity and antigen assays were performed for the studied patients. Genotyping of F9 for identifying genetic mutations was conducted by the Sanger sequencing method following PCR amplification of the promoter region and all the eight exons of the F9 gene. Results: The mean age of patients was 4 years (9 months to 16 years) and consanguinity was reported in 80% of cases. Patients were commonly manifested by hematoma (90%), epistaxis (80%), and hemarthrosis (70%) and the severity of the disorder was severe (70%) or moderate (30%). In nine out of 10 patients a genetic defect in F9 gene we detected including three missense (c.304T>C, c.1007T>A, c.191G>A) and three nonsense mutations (c.892C>T, c.880C>T, c.1113C>A). Based on the FIX variant database (http://www.factorix.org), five mutations have been reported previously, but mutation c.1007T>A (p.Ile336Asn) seems to be a novel mutation. Conclusion: Our results indicated the heterogeneous molecular defects of hemophilia B in Iran, as recorded in the FIX mutation database. Moreover, no specific genotype-phenotype association was observed in studied subjects.

Keywords

References

1.
References are in the PDF file of the article.

Unusual Prevalence of c559T > C Mutation in Patients with Factor XIII deficiency in Southeast of Iran

Ebrahim Miri-Moghaddam,

Yasaman Garmie,

Majid Naderi

Miri-Moghaddam E, Garmie Y, Naderi M. Unusual Prevalence of c559T > C Mutation in Patients with Factor XIII deficiency in Southeast of Iran. Gene Cell Tissue. 2014;1(1):e18314. doi: https://doi.org/10.17795/gct-18314

19

Jul

2011

Prevalence of factor VIII inhibitor in patients with hemophilia A in Sanandaj

Farzad Company,

Nazila Rezaei,

Mariam Aliasgharpoor

Company F, Rezaei N, Aliasgharpoor M. Prevalence of factor VIII inhibitor in patients with hemophilia A in Sanandaj. J Kermanshah Univ Med Sci. 2011;15(2):e79379. doi:

30

Sep

2008

Survey of the relationship between of thrombophilic factors and the rate and severity of bleeding in patients with severe hemophilia A

Mohammad Faranosh,

Navid Danayie,

raheb Ghorbani,

Mahbobeh Rahamani,

Mohammad Jazebi,

Tahere Shashani

,et al.

Faranosh M, Danayie N, Ghorbani R, Rahamani M, Jazebi M, et al. Survey of the relationship between of thrombophilic factors and the rate and severity of bleeding in patients with severe hemophilia A. koomesh. 2024;9(4):e152211. doi:

29

Oct

2023

Evaluation of Cardiovascular Status in Hemophilia Patients in Dezful: Echocardiography, Electrocardiography, and Cardiac Risk Factors

Hakimeh Saadatifar,

Rezvan Behrouzi,

Aziz Ghorban Shiravizadeh,

Neda Shakerian,

Samira Saadatifar

Saadatifar H, Behrouzi R, Shiravizadeh AG, Shakerian N, Saadatifar S. Evaluation of Cardiovascular Status in Hemophilia Patients in Dezful: Echocardiography, Electrocardiography, and Cardiac Risk Factors. J Adv Immunopharmacol. 2023;3(2):e139250. doi: https://doi.org/10.5812/tms-139250

1

Jan

2017

Genetic Risk Factors for Inhibitor Development in Patients with Hemophilia and Rare Bleeding Disorders

Taregh Bamedi,

Ghazaleh Dadashizadeh,

Afsaneh Sarabandi,

Shadi Tabibian,

Mahmood Shams,

Akbar Dorgalaleh

Bamedi T, Dadashizadeh G, Sarabandi A, Tabibian S, Shams M, et al. Genetic Risk Factors for Inhibitor Development in Patients with Hemophilia and Rare Bleeding Disorders. J Cell Mol Anesth. 2017;2(1):e149529. doi: https://doi.org/10.22037/jcma.v2i1.14481

Import into EndNote Import into BibTex

Crossmark

Checking

Share on

Comments

Number of Comments:0

Cited by

Scopus by DOI: 1
Last Update: 3 weeks ago
Scopus by Title: 1
Last Update: 3 weeks ago
Scopus by Title (Ref): 1
Last Update: 3 weeks ago
CrossRef: 0
Last Update: 4 days ago

Metrics

Licensing and reuse information

Ordering Reprints

Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC

Search Relations

Author(s):

marzieh shakouri:[PubMed][Scholar]
Maryam Sadat Hosseini:[PubMed][Scholar]
Akbar Dorgalaleh:[PubMed][Scholar]
Minoo Shahidi:[PubMed][Scholar]
Farhad Zaker:[PubMed][Scholar]

Outlines

Complete Genotype and Clinical Phenotype of Hemophilia B: A Study on Iranian Patients

Abstract

References

Similar Articles

Unusual Prevalence of c559T > C Mutation in Patients with Factor XIII deficiency in Southeast of Iran

Prevalence of factor VIII inhibitor in patients with hemophilia A in Sanandaj

Survey of the relationship between of thrombophilic factors and the rate and severity of bleeding in patients with severe hemophilia A

Evaluation of Cardiovascular Status in Hemophilia Patients in Dezful: Echocardiography, Electrocardiography, and Cardiac Risk Factors

Genetic Risk Factors for Inhibitor Development in Patients with Hemophilia and Rare Bleeding Disorders

Crossmark

Checking

Last Update: 3 weeks ago

Last Update: 3 weeks ago

Last Update: 3 weeks ago

Last Update: 4 days ago